BIO 2021 Notebook: Going Fast And Being Precise

News and views from day three of the BIO Digital annual meeting include Amgen’s CEO on speedy development and NIH’s chief on bringing personalized medicine to COVID vaccines.

BIO 2021 Notebook - Day 3
CHINA’S DECISION TO SUPPORT COVID PATENT WAIVERS WAS CALLED A 'BOLD ACT' AT THE BIO ANNUAL MEETING.

More from Clinical Trials

More from R&D